Alaunos Therapeutics TCRT

Price Adrian updates its stake in Alaunos Therapeutics to 8.6%

Form
Schedule 13D/A
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by Adrian Price (amended)

Get an email when Alaunos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.